Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
4
×
biogen
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
4
×
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aduro biotech
bristol-myers squibb
clinical trials
deals
investing
medicare
pfizer
What
bio
roundup
drug
alzheimer’s
companies
price
prices
alliance
annual
approval
assessed
attention
biogen’s
biopharmaceutical
biotech
bristol
buy
calls
changing
color
communities
conference
convo
crispr
days
different
earlier
esmo
europe
fail
failures
gene
germany
growing
hosted
hours
increases
investment
kudos
latest
Language
unset
Current search:
national
×
biotech
×
" cancer immunotherapy "
×
" eli lilly "
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More